At AstraZeneca, data and AI are more than game changers – they are life changers

As one of the world's largest biopharmaceutical companies, AstraZeneca pushes the boundaries of science to deliver life-changing medicines that create enduring value for patients and society. To accelerate growth through innovation, the company is expanding its use of data science and artificial intelligence (AI) across the business to improve patient outcomes. AstraZeneca has been on a multiyear journey to transform its scientific capabilities to enhance its understanding of disease, design next-generation therapeutics, pioneer new clinical approaches, and better predict clinical success. For example, as part of its efforts to unlock different human genomes, AstraZeneca is working toward the analysis of up to 2 million individual genomes by 2026. This initiative alone has generated an explosion in the quantity and complexity of data the company collects, stores, and analyzes for insights.